[go: up one dir, main page]

EP0204989A3 - Use of penicillamine in the treatment of immune deficiency diseases - Google Patents

Use of penicillamine in the treatment of immune deficiency diseases Download PDF

Info

Publication number
EP0204989A3
EP0204989A3 EP86106646A EP86106646A EP0204989A3 EP 0204989 A3 EP0204989 A3 EP 0204989A3 EP 86106646 A EP86106646 A EP 86106646A EP 86106646 A EP86106646 A EP 86106646A EP 0204989 A3 EP0204989 A3 EP 0204989A3
Authority
EP
European Patent Office
Prior art keywords
penicillamine
immune deficiency
treatment
deficiency diseases
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP86106646A
Other languages
German (de)
Other versions
EP0204989B1 (en
EP0204989A2 (en
Inventor
Prakash Prof. Dr. Phil. Nat. Chandra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma AG filed Critical Asta Pharma AG
Priority to AT86106646T priority Critical patent/ATE73995T1/en
Publication of EP0204989A2 publication Critical patent/EP0204989A2/en
Publication of EP0204989A3 publication Critical patent/EP0204989A3/en
Application granted granted Critical
Publication of EP0204989B1 publication Critical patent/EP0204989B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention is directed to the use of penicillamine for controlling illnesses, e.g., AIDS, which are distinguished by an immune deficiency syndrome.
EP86106646A 1985-06-08 1986-05-15 Use of penicillamine in the treatment of immune deficiency diseases Expired - Lifetime EP0204989B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT86106646T ATE73995T1 (en) 1985-06-08 1986-05-15 USE OF PENICILLAMIN TO TREAT IMMUNE DEFICIENCY DISEASES.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3520624 1985-06-08
DE3520624 1985-06-08

Publications (3)

Publication Number Publication Date
EP0204989A2 EP0204989A2 (en) 1986-12-17
EP0204989A3 true EP0204989A3 (en) 1989-12-20
EP0204989B1 EP0204989B1 (en) 1992-03-25

Family

ID=6272806

Family Applications (1)

Application Number Title Priority Date Filing Date
EP86106646A Expired - Lifetime EP0204989B1 (en) 1985-06-08 1986-05-15 Use of penicillamine in the treatment of immune deficiency diseases

Country Status (8)

Country Link
US (1) US4847297A (en)
EP (1) EP0204989B1 (en)
JP (1) JPS61286325A (en)
AT (1) ATE73995T1 (en)
AU (1) AU584551B2 (en)
CA (1) CA1283859C (en)
DE (1) DE3684514D1 (en)
ZA (1) ZA864263B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
MX9205549A (en) * 1991-09-30 1993-05-01 Jess G Thoene METHOD FOR THE TREATMENT OF HIV.
US6764693B1 (en) 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
CA2173964A1 (en) * 1993-10-15 1995-04-20 Jess G. Thoene Prevention of hiv infection
US6541517B1 (en) 1999-09-03 2003-04-01 Donald M. Murphy Treatment of skin disorders
US6117904A (en) * 1999-09-03 2000-09-12 Murphy; Donald M. Treatment of pruritus
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms
US20100166833A1 (en) * 2007-05-07 2010-07-01 Technion Research & Development Foundation Ltd. Compositions, articles and methods for preventing or reducing tobacco-associated damage
US20190282519A1 (en) * 2018-03-19 2019-09-19 Cronus Research Labs Private Limited Pencillamine oral composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB585413A (en) * 1944-06-19 1947-02-06 Wellcome Found Improved method for the resolution of penicillamine
GB1424432A (en) * 1972-03-25 1976-02-11 Degussa Pharmaceutical compositions
CH588887A5 (en) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US4487780A (en) * 1979-09-18 1984-12-11 Scheinberg Israel H Method of treatment of rheumatoid arthritis

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Arzneimittelforsch./Drug Res., Band 36, Nr. 2, Februar 1986, Aulendorf, DE, P. CHANDRA et al.: "Selective inhibition of replication of the AIDS-associated virus HTLV-III/LAV by synthetic D-penicillamine, Ganze Dokument. *
Boletino Soc. Italiana Biologica Sperimentale, Band 43, 1967, Seiten 645-647, Napoli, IT, P. MAZZUCATO et al.: "Attivita antivirale della guanidina E della D-penicillamina. II. Studio comparato degli antagonisti della guanidina E della D-penicillamina", Seite 645; Figur 2. *
Concours Medical, Band 100, 23. Dezember 1978, Seiten 7845-7850, Paris, FR, V. LEMAIRE: "Les traitements a visée immunologique en rhumatologie", Seite 7850: "Immuno-stimulation". *
Int. Journal of Immunotherapy, Band I, Nr. 2, 1985, Seiten 79-83, Bioscience Ediprint Inc., CH, Y. SHIOKAWA: "Progress in new immunomodulator research", Ganze Dokument, Insbes. Tabelle IV. *
Nouvelle Presse Medicale, Band 1, Nr. 14, Seiten 953-958, 1972, Paris, FR, G.H. WERNER: "La multiplication des virus. 2. Perspectives d'avenir de la chimiotherapie antivirale", Seiten 953-954; conclusions. *
Postgraduate Med. J., Suppl., Band 50, 1974, Seiten 50-55, London, GB, I.A. JAFFE et al.: "Further studies of the anti-viral effect of D-penicillamine", Zusammenfassung; Introduction. *
The Merck Manual of Diagnosis and Therapy, R. BERKOW, M.D. Editor; 14. Auflage, 1982, MSD Research Lab. Rahway, NJ, US, Seiten 288-304. *

Also Published As

Publication number Publication date
ATE73995T1 (en) 1992-04-15
EP0204989B1 (en) 1992-03-25
ZA864263B (en) 1987-02-25
CA1283859C (en) 1991-05-07
JPS61286325A (en) 1986-12-16
EP0204989A2 (en) 1986-12-17
AU584551B2 (en) 1989-05-25
JPH0380772B2 (en) 1991-12-26
DE3684514D1 (en) 1992-04-30
US4847297A (en) 1989-07-11
AU5844086A (en) 1986-12-11

Similar Documents

Publication Publication Date Title
OA08581A (en) Treatment of diseases caused by retroviruses.
NO883007D0 (en) PROCEDURE FOR THE PREPARATION OF BENZOPYRANE DERIVATIVES.
AU1256288A (en) Treatment of human viral infections by dsrna combined with viral inhibitors
ZW22687A1 (en) Treatment of diseases caused by viruses
FI884095A7 (en) DOSERINGSVENTIL MED HOPFAELLBAR CHAMBER.
EP0204989A3 (en) Use of penicillamine in the treatment of immune deficiency diseases
NO882388D0 (en) PROCEDURE FOR THE PREPARATION OF CONTAMINATED MINERALS.
GR3006674T3 (en)
GR3019860T3 (en) R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, process for its preparation and medicines containing it
NO881636D0 (en) PROCEDURE FOR THE MANUFACTURE OF FIBER-CONTAINED SOY MILK.
GB2179858B (en) Compositions for treating viral skin diseases.
ZA884262B (en) Pharmaceutical composition for the treatment of tumors
IT8721560A0 (en) PROCEDURE FOR THE PURIFICATION OF INTERFERON.
AU3660284A (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
NO880292D0 (en) PROCEDURE FOR HUMAN TREATMENT.
ZA929879B (en) Compositions for the treatment of mammalian diseases.
NO873727L (en) PROCEDURE FOR THE PREPARATION OF BENZOCSAZONE RELATIONS WITH THERAPEUTIC ACTIVITY.
NO164972C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE GEM-DIHALO-1,8-DIAMINO-4-AZA OCTANES.
ZA875676B (en) The use of 15-deoxyspergualine as a pharmaceutical
NO884792L (en) PROCEDURE FOR THE PREPARATION OF ALFA-OLEPHINE POLYMES.
IT8719427A0 (en) PROCEDURE FOR THE PREPARATION OF AGENTS FOR THE TREATMENT OF GASEOUS COMBUSTION PRODUCTS.
NO884635L (en) PROCEDURE FOR TREATMENT OF FEEDS.
GR3005231T3 (en)
EP0245368A4 (en) Treatment of demyelinating diseases.
AU7398587A (en) Treatment of soybeans

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19860515

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ASTA PHARMA AKTIENGESELLSCHAFT

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19901015

ITF It: translation for a ep patent filed
GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ASTA MEDICA AKTIENGESELLSCHAFT

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

REF Corresponds to:

Ref document number: 73995

Country of ref document: AT

Date of ref document: 19920415

Kind code of ref document: T

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19920410

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19920429

Year of fee payment: 7

REF Corresponds to:

Ref document number: 3684514

Country of ref document: DE

Date of ref document: 19920430

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19920508

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Effective date: 19920515

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19920526

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 19920527

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19920531

Year of fee payment: 7

ET Fr: translation filed
GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)
EPTA Lu: last paid annual fee
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19930515

Ref country code: GB

Effective date: 19930515

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19930516

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19930528

Year of fee payment: 8

ITTA It: last paid annual fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19930531

Ref country code: CH

Effective date: 19930531

Ref country code: BE

Effective date: 19930531

BERE Be: lapsed

Owner name: ASTA MEDICA A.G.

Effective date: 19930531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19931201

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19930515

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19941221

Year of fee payment: 9

EUG Se: european patent has lapsed

Ref document number: 86106646.2

Effective date: 19931210

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Effective date: 19950131

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19960201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050515